Advertisement
News
Advertisement

Board of Directors declares 10 percent increase in quarterly dividend

Mon, 02/27/2012 - 3:45am
The Associated Press

ST. PAUL, Minn.--(BUSINESS WIRE)--Feb 27, 2012-- St. Jude Medical, Inc. (NYSE:STJ), a global medical device company, today announced that its Board of Directors declared a 10 percent increase in the company's quarterly dividend to $0.23 per common share. At the new rate, the annual dividend would be $0.92 per share, compared to the previous annual dividend of $0.84 per share. The dividend is payable April 30, 2012, to shareholders of record on March 30, 2012.

Commenting on the dividend increase, St. Jude Medical Chairman, President and Chief Executive Officer Daniel J. Starks said, "St. Jude Medical has a long track record of returning capital to our shareholders. This increase in our cash dividend demonstrates our commitment to maintaining a meaningful dividend payout over time without sacrificing our ability to invest in our robust portfolio of product development initiatives designed to accelerate our revenue growth." About St. Jude Medical St. Jude Medical develops medical technology and services that focus on putting more control into the hands of those who treat cardiac, neurological and chronic pain patients worldwide. The company is dedicated to advancing the practice of medicine by reducing risk wherever possible and contributing to successful outcomes for every patient. St. Jude Medical is headquartered in St. Paul, Minn. and has four major focus areas that include: cardiac rhythm management, atrial fibrillation, cardiovascular and neuromodulation. For more information, please visit sjm.com.

Forward-Looking Statements This news release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995 that involve risks and uncertainties. Such forward-looking statements include the expectations, plans and prospects for the Company, including potential clinical successes, anticipated regulatory approvals and future product launches, and projected revenues, margins, earnings and market shares. The statements made by the Company are based upon management's current expectations and are subject to certain risks and uncertainties that could cause actual results to differ materially from those described in the forward-looking statements. These risks and uncertainties include market conditions and other factors beyond the Company's control and the risk factors and other cautionary statements described in the Company's filings with the SEC, including those described in the Risk Factors and Cautionary Statements sections of the Company's Annual Report on Form 10-K for the fiscal year ended January 1, 2011 and Quarterly Report on Form 10-Q for the fiscal quarter ended October 1, 2011. The Company does not intend to update these statements and undertakes no duty to any person to provide any such update under any circumstance.

CONTACT: St. Jude Medical, Inc.

J.C. Weigelt, 651-756-4347 Investor Relations jweigelt@sjm.com KEYWORD: UNITED STATES NORTH AMERICA MINNESOTA INDUSTRY KEYWORD: HEALTH BIOTECHNOLOGY HOSPITALS MEDICAL DEVICES PROFESSIONAL SERVICES FINANCE SOURCE: St. Jude Medical, Inc.

Copyright Business Wire 2012 PUB: 02/27/2012 08:01 AM/DISC: 02/27/2012 08:01 AM http://www.businesswire.com/news/home/20120227005591/

Advertisement

Share this Story

X
You may login with either your assigned username or your e-mail address.
The password field is case sensitive.
Loading